Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells

K Sugawara1, M Hamada, S Hosoi

  • 1Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Japan.

Analytical Biochemistry
|February 6, 1998
PubMed
Summary

Developing a new assay for osteoclast bone resorption is crucial for osteoporosis treatment. This method measures calcium release from dentin, offering a simple, quantitative way to screen for bone resorption inhibitors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GloBIAS: strengthening the foundations of BioImage Analysis.

ArXiv·2025
Same author

Spin-valley coupling enhanced high-T<sub>C</sub> ferromagnetism in a non-van der Waals monolayer Cr<sub>2</sub>Se<sub>3</sub> on graphene.

Nature communications·2025
Same author

Test of the negative feedback hypothesis of colony size sensing in social insects.

Biology letters·2024
Same author

Observation of edge states derived from topological helix chains.

Nature·2024
Same author

Antiferromagnetic topological insulator with selectively gapped Dirac cones.

Nature communications·2023
Same author

Female pattern hair loss with acromegaly.

Clinical and experimental dermatology·2020

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Postmenopausal osteoporosis is characterized by excessive bone resorption.
  • Controlling osteoclast activity is key to managing osteoporosis.
  • A simple, quantitative assay is needed to screen for bone resorption inhibitors.

Purpose of the Study:

  • To develop a novel in vitro method for assessing osteoclast bone resorption.
  • To establish a screening system for identifying novel bone resorption inhibitors.

Main Methods:

  • Prepared mouse osteoclast-like multinucleated cells in vitro.
  • Placed cells on dentin slices to measure released calcium.
  • Assessed calcitonin's dose-dependent inhibitory effect on bone resorption.
  • Correlated calcium release with pit area reduction.

Related Experiment Videos

Main Results:

  • The developed method showed significant, dose-dependent inhibition by calcitonin.
  • Calcium release reduction correlated with decreased pit area.
  • Known inhibitors (bisphosphonate, bafilomycin A1, herbimycin A) demonstrated inhibitory effects.

Conclusions:

  • The novel calcium release assay is a simple and quantitative method for screening bone resorption inhibitors.
  • This system facilitates the discovery of compounds with new mechanisms of action.
  • The assay is effective in evaluating the efficacy of known bone resorption inhibitors.